Soleno Therapeutics Inc (SLNO)
44.99
-2.65
(-5.56%)
USD |
NASDAQ |
May 10, 16:00
45.02
+0.04
(+0.08%)
After-Hours: 20:00
Soleno Therapeutics Net Income (Quarterly): -11.30M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.30M |
| September 30, 2023 | -10.86M |
| June 30, 2023 | -8.475M |
| March 31, 2023 | -8.356M |
| December 31, 2022 | -5.486M |
| September 30, 2022 | -6.132M |
| June 30, 2022 | -6.725M |
| March 31, 2022 | -5.724M |
| December 31, 2021 | -2.828M |
| September 30, 2021 | -8.14M |
| June 30, 2021 | -10.99M |
| March 31, 2021 | -8.954M |
| December 31, 2020 | -2.852M |
| September 30, 2020 | -8.545M |
| June 30, 2020 | -7.384M |
| March 31, 2020 | -5.858M |
| December 31, 2019 | -14.62M |
| September 30, 2019 | 0.889M |
| June 30, 2019 | -10.01M |
| March 31, 2019 | -7.03M |
| December 31, 2018 | 0.263M |
| September 30, 2018 | -2.736M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.058M |
| March 31, 2018 | -3.804M |
| December 31, 2017 | -4.743M |
| September 30, 2017 | -3.786M |
| June 30, 2017 | -3.969M |
| March 31, 2017 | -2.887M |
| December 31, 2016 | -2.613M |
| September 30, 2016 | -2.75M |
| June 30, 2016 | -3.513M |
| March 31, 2016 | -3.189M |
| December 31, 2015 | -2.844M |
| September 30, 2015 | -3.293M |
| June 30, 2015 | 1.881M |
| March 31, 2015 | -11.65M |
| December 31, 2014 | -7.219M |
| September 30, 2014 | -2.393M |
| June 30, 2014 | -2.793M |
| March 31, 2014 | -0.834M |
| December 31, 2013 | -0.9742M |
| September 30, 2013 | -1.59M |
| June 30, 2013 | -2.157M |
| March 31, 2013 | 1.014M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-14.62M
Minimum
Dec 2019
0.889M
Maximum
Sep 2019
-7.492M
Average
-8.14M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Avid Bioservices Inc | -6.006M |
| Creative Medical Technology Holdings Inc | -1.679M |
| Viking Therapeutics Inc | -27.36M |
| Avenue Therapeutics Inc | 0.64M |
| Mind Medicine Inc | -54.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 12.83M |
| EPS Diluted (Quarterly) | -0.3566 |
| Enterprise Value | 1.291B |
| Earnings Yield | -6.66% |
| Normalized Earnings Yield | -153.86 |